Filtered By:
Specialty: Internal Medicine
Source: Journal of Internal Medicine
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 67 results found since Jan 2013.
Reply: Proton ‐Pump Inhibitor Use and the Risk of First‐Time Ischemic Stroke in the General Population
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - November 1, 2017 Category: Internal Medicine Authors: Thomas S. G. Sehested, Mark A. Hlatky, Nicholas Carlson, Gunnar H. Gislason Tags: Letter to the Editor Source Type: research
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE ‐LY trial
ConclusionsAmongst the current clinical bleeding risk scores, the ORBIT score demonstrated the best discrimination and calibration. All the scores demonstrated, to a variable extent, an interaction with bleeding risk associated with dabigatran or warfarin.
Source: Journal of Internal Medicine - November 7, 2017 Category: Internal Medicine Authors: M. Proietti, Z. Hijazi, U. Andersson, S. J. Connolly, J. W. Eikelboom, M. D. Ezekowitz, D. A. Lane, J. Oldgren, V. Roldan, S. Yusuf, L. Wallentin, Tags: Original Article Source Type: research
Proton ‐Pump Inhibitor use and the risk of Ischaemic Stroke
Click here to view the Letter to the Editor by Dr. Sehested et al.
Source: Journal of Internal Medicine - November 26, 2017 Category: Internal Medicine Authors: C. Dai, M. Jiang, Q. Cao Tags: Letter to the Editor Source Type: research
Management of acute ischaemic stroke in patients with dementia
Source: Journal of Internal Medicine - February 20, 2018 Category: Internal Medicine Tags: Corrigendum Source Type: research
CCL23 is a promising biomarker of injury in patients with ischaemic stroke
Click here to view the Original Article by A. Simats et al.
Source: Journal of Internal Medicine - March 5, 2018 Category: Internal Medicine Authors: A. Bonaventura, F. Montecucco Tags: Editorial Comment Source Type: research
Anti ‐Inflammatory Therapy for Atherosclerosis:Interpreting Divergent Results from the CANTOS and CIRT Clinical Trials
This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - November 25, 2018 Category: Internal Medicine Authors: Paul M Ridker Tags: Commentary Source Type: research
